Pushkal Garg, CMO & EVP Development & Med Affairs at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 1,287 shares at $242.44 ($311K) on 2025-02-28, disclosed to the SEC on 2025-03-03.
Open-market sale of $311k ALNY by CMO & EVP Development & Med Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $236.51 | 51 | $12K | 3.9% |
| 2 | $238.33 | 40 | $10K | 3.1% |
| 3 | $239.18 | 41 | $10K | 3.1% |
| 4 | $240.32 | 91 | $22K | 7.0% |
| 5 | $241.51 | 149 | $36K | 11.6% |
| 6 | $242.44 | 352 |
| $85K |
| 27.4% |
| 7 | $242.44 | 352 | $85K | 27.4% |
| 8 | $243.23 | 142 | $35K | 11.1% |
| 9 | $244.11 | 69 | $17K | 5.4% |
| Total | $241.89 avg | 1,287 | $311K | 100% |
| Filing → |
| ALNY | SELL | 2026-03-02 | $1.5M | — | Filing → |
| ALNY | SELL | 2026-02-17 | $695K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |